Latest News
March 10, 2022
Bayer to sell its Environmental Science Professional business to Cinven for 2.6 billion U.S. dollars
March 01, 2022
Fiscal 2021:
Bayer: Dynamic growth – progress in innovation
February 21, 2022
Not intended for U.S. and UK Media
Bayer’s new treatment Kerendia® (finerenone) approved in EU for adult patients with chronic kidney disease associated with type 2 diabetes
Our Stories
Please enter a term to search